Maxcyte, Inc. (MXCT) on GreekSoup

Maxcyte, Inc.: Schedule 13D filed by Liontrust Investment Partners LLP, 5.0% of the class

Thu, 15 Oct 2026 00:00:00 +0000

(a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer

Schedule 13D/13G. The filing. The page on GreekSoup.

Maxcyte, Inc.: short interest 1,831,817 shares at the 15 October 2026 settlement, 1.07 days to cover

Thu, 15 Oct 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Maxcyte, Inc. filed 8-K: results of operations

Wed, 14 Oct 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Maxcyte, Inc.: short interest 1,089,972 shares at the 30 September 2026 settlement, 3.14 days to cover

Wed, 30 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Maxcyte, Inc.: short interest 1,170,407 shares at the 15 September 2026 settlement, 2.81 days to cover

Tue, 15 Sep 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Maxcyte, Inc.: short interest 1,301,713 shares at the 31 August 2026 settlement, 2.37 days to cover

Mon, 31 Aug 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Maxcyte, Inc.: short interest 1,225,669 shares at the 14 August 2026 settlement, 1.13 days to cover

Fri, 14 Aug 2026 00:00:00 +0000

Short interest. The filing. The page on GreekSoup.

Maxcyte, Inc. Q2 FY2026 results: revenue $7 million, net income -$9 million

Thu, 13 Aug 2026 00:00:00 +0000

Results. The filing. The page on GreekSoup.

Maxcyte, Inc. filed 10-Q: 10-q

Thu, 13 Aug 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Maxcyte, Inc. filed 8-K: results of operations, regulation fd disclosure

Wed, 12 Aug 2026 00:00:00 +0000

SEC filing. The filing. The page on GreekSoup.

Maxcyte, Inc.: Schedule 13D filed by RIVER GLOBAL INVESTORS LLP, 0.8% of the class

Tue, 04 Aug 2026 00:00:00 +0000

(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited. Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds. The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP

Schedule 13D/13G. The filing. The page on GreekSoup.